Completed
AGA Institute Guidelines on Hepatitis B Reactivation Clinical Decision Tool
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Liver Disorders - Hepatitis B - Steven-Huy Han, MD, UCLA - UCLA Digestive Diseases
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Hepatitis B is a Devastating Global Healthcare Issue
- 3 Where Are the Long-term HBV Carriers?
- 4 How Do You Acquire the Infection in the West?
- 5 Outcome of HBV by Age of Infection
- 6 Elimination of HBV Transmission
- 7 Progression of Hepatitis B Infection
- 8 Diagnosis of HBV Infection: Using Serum Markers
- 9 REVEAL Study
- 10 Indications for antiviral therapy HBeAg Positive CHB
- 11 Indications for antiviral therapy HBeAg Negative CHB
- 12 Endpoints of antiviral therapy HBeAg Negative CHB
- 13 Indications for antiviral therapy Compensated Cirrhosis
- 14 American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
- 15 AGA Institute Guidelines on Hepatitis B Reactivation Clinical Decision Tool
- 16 Strategies to Eradicate Chronic HBV
- 17 Type of Chronic HBV Control and Cure
- 18 What Might a HBV Curative Regimen Look Like?
- 19 Conclusions
